While Miran is still considered a dark horse to replace Powell as Fed Chair when his term expires in May of 2026, his views ...

The European Commission is considering including a provision in its upcoming sanctions package that would phase out all Russian LNG imports before the end of 2027, which was the EU’s original timeline ...

UBS cut ratings on both Box and Dropbox, saying demand for their AI-driven offerings is not yet strong enough to offset slowing growth in cloud storage. The brokerage downgraded Box to Neutral from ...

Investing.com -- Morgan Stanley said recent softness in copper prices should prove temporary, despite signs of demand ...

Piper Sandler raised its price targets for both Alphabet and Reddit following fresh advertising data and positive company ...

"The United States is getting a tremendous fee plus. I call it a fee plus for just making the deal," Trump stated during a joint news conference with British Prime Minister Keir Starmer. The President ...

Live Nation Entertainment (NYSE:LYV) stock fell 3% on Thursday after the Federal Trade Commission and seven states filed a lawsuit against the company and its Ticketmaster subsidiary over alleged ...

Investing.com -- Advanced Drainage Systems Inc. is in advanced talks to acquire the water management unit of Germany’s Norma Group SE in a deal valued at approximately €850 million ($1 billion), ...

Investing.com -- JPMorgan Chase & Co ’s high-yield credit trading desk facilitated the sale of Worldline SA bonds previously held by the European Central Bank in a transaction valued at approximately ...

Investing.com -- DraftKings (NASDAQ:DKNG) stock pared gains but remained higher by 0.4% after being identified as a short target in a report by The Bear Cave, which claims prediction markets pose a ...

For data centers, Intel will build Nvidia-custom x86 CPUs that Nvidia will integrate into its AI infrastructure platforms. In ...

Investing.com -- Nektar Therapeutics (NASDAQ:NKTR) stock jumped 7% Thursday after the company announced positive results from its REZOLVE-AD Phase 2b study of rezpegaldesleukin for moderate-to-severe ...